CEP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CEP, covering 2025-07-01 to 2025-07-01. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of CEP+Dasatinib + Azacytidine in First-line Treatment of. Angioimmunoblastoma Foresight [Phase 4]